(Total Views: 409)
Posted On: 11/10/2019 12:00:31 PM
Post# of 154899
Tech Guru , - this was a good post but I was thinking about it .,
Well , to be accepted to our mono , patients must be on HAART , and with VL <50copies /ml..
Those are patients with good viral suppression , not newly diagnosed .
Good results are when viral load is not going up when HAART is stopped and patient is only on Leronlimab .
Patients who will want to change to Leronlimab are patients who don’t want to swallow tabl every day , they don’t want to develop resistance , and they do have , or don’t want to develop side effects from HAART .,
IMO as always ..
Well , to be accepted to our mono , patients must be on HAART , and with VL <50copies /ml..
Those are patients with good viral suppression , not newly diagnosed .
Good results are when viral load is not going up when HAART is stopped and patient is only on Leronlimab .
Patients who will want to change to Leronlimab are patients who don’t want to swallow tabl every day , they don’t want to develop resistance , and they do have , or don’t want to develop side effects from HAART .,
IMO as always ..
(0)
(0)
